Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2028

Conditions
Choline DeficiencyLiver Injury
Interventions
DRUG

Choline Chloride for Injection

Intravenous use

DRUG

Placebo

Water for injection

Trial Locations (14)

2100

Rigshospitalet - University Hospital Copenhagen, Copenhagen

3000

University Hospitals Leuven, Campus Gasthuisberg, Leuven

9100

Aalborg University Hospital, Department of Medical Gastroenterology, Aalborg

10032

Columbia University Medical Center/ New York Presbyterian Hospital, New York

13353

Charite - University Hospital Berlin, Berlin

27710

Duke Clinic - Abdominal Transplant Research Office, Durham

35000

Rennes University Hospital Center - Pontchaillou Site, Rennes

44195

Cleveland Clinic, Cleveland

45147

University Duisburg-Essen, University Hospital Essen, Essen

45229

Cincinnati Children's Hospital, Division of Gastroenterology, Hepatology & Nutrition, Cincinnati

54511

CHRU Nancy - Barbois Hospital, Vandœuvre-lès-Nancy

80045

University of Colorado School of Medicine, Aurora

92110

Beaujon Hospital - APHP, Clichy

00-739

Czerniakowski Hospital Sp. z o.o. (LCC), Warsaw

Sponsors
All Listed Sponsors
lead

Protara Therapeutics

INDUSTRY